The Collection of Epidemiological Data of the Women Undergoing Mammography in Suburban Area of Mersin

Yıl 2019, Cilt: 5 Sayı: 2, 155 - 159, 01.04.2019

Mehmet Ercument Dogen

https://doi.org/10.5455/umj.20190318070023

Öz

Background: The study aimed to evaluate the epidemiologic data of our patients with mammography examinations, pre-examinations, and evaluation of them. Materials and Methods: This cross-sectional study was conducted by asking specific questions by face-to-face interviewing 500 female patients who lived in the suburban areas of Mersin between April 2011 and November 2011 and who applied to the maternity branch hospital for mammography surveys. The data are evaluated proportionally; numerical values are given in percent and n=n1/total number. Results: The majority of the cases 87%, n=435/500 consisted of women aged 40-60 years. The majority of cases 80%, n=400/500 reported that the education level was primary school graduate or lower. In our patients, 54% n=270/500 had no previous mammography screening, 43% n=215/500 had irregular mammography screening, 3% n=15/500 had a regular mammography scan. 55% n=275/500 did not know what the mammography was and why it was withdrawn; 45% n=225/500 did not know enough. Our cases of 12% n=60/500 had a history of breast cancer in the family. Conclusion: Collection of epidemiologic data belonging to the patient before the mammography screening will benefit the planning of future surveys, and it is seen that they are also contributing to the reporting of mammography.

Anahtar Kelimeler

Mammography, epidemiology, breast cancer, menopause.

Kaynakça

• 1. Dahnert W. Radiology Review Manual. 4th ed. Baltimore: Williams and Wilkins, 1999;455-465
• 2. Malmgren JA, Parikh J, Atwood MK, Kaplan HG. Impact of mammography detection on the course of breast cancer in women aged 40-49 years. Radiology 2012 Mar;262(3):797- 806
• 3. WHO Position Paper on Mammography Screening Geneva: World Health Organization; 2014. ISBN-13: 978-92-4-150 793-6
• 4. Advisory Committee on Breast Cancer Screening. Screening for breast cancer in England: past and future. J Med Screen. 2006;13(2):59-61
• 5. Kurth AE, Krist AH, Borsky AE, Baumann LC, Curry SJ, Davidson KW, Doubeni CA, Epling JW Jr, Fan T, García FAR, Herzstein J, Phillips WR, Pignone MP, Tseng CW, Weinstein R. U.S. Preventive Services Task Force Methods to Communicate and Disseminate Clinical Preventive Services Recommendations. Am J Prev Med. 2018 Jan;54(1S1):S81-87
• 6. Haukka J, Byrnes G, Boniol M, Autier P. Trends in breast cancer mortality in Sweden before and after implementation of mammography screening. PLoS One. 2011;6(9):e22422.
• 7. Autier P, Héry C, Haukka J, Boniol M, Byrnes G. Advanced breast cancer and breast cancer mortality in randomized controlled trials on mammography screening. J Clin Oncol. 2009 Dec 10;27(35):5919-23
• 8. Bennett RL, Blanks RG, Patnick J, Moss SM. Results from the UK NHS Breast Screening Programme 2000-05. J Med Screen. 2007;14(4):200-204
• 9. Hendrick RE, Smith RA, Rutledge JH 3rd, Smart CR. Benefit of screening mammography in women aged 40-49: a new meta-analysis of randomized controlled trials. J Natl Cancer Inst Monogr. 1997;(22):87-92
• 10.Fletcher SW, Black W, Harris R, Rimer BK, Shapiro S. J. Report of the International Workshop on Screening for Breast Cancer. Natl Cancer Inst. 1993; Oct 20;85(20):1644-56
• 11.Tabár L, Vitak B, Chen TH, Yen AM, Cohen A, Tot T, Chiu SY, Chen SL, Fann JC, Rosell J, Fohlin H, Smith RA, Duffy SW. Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades. Radiology. 2011, 260: 658-663
• 12.Kopans DB. Do not jump too quickly to conclusions. Breast Cancer Res. 2012;14(4):108
• 13.Day NE. The NHS breast cancer screening programme. Br J Cancer. 2003 Jul 7;89(1):1
• 14.Harding C, Pompei F, Burmistrov D, Welch HG, Abebe R, Wilson R. Breast Cancer Screening, Incidence, and Mortality Across US Counties. JAMA Intern Med. 2015 Sep;175(9):1483-9
• 15.Karimi P, Shahrokni A, Moradi S. Evidence for U.S. Preventive Services Task Force (USPSTF) recommendations against routine mammography for females between 40-49 years of age. Asian Pac J Cancer Prev. 2013;14(3):2137-9
• 16.Sankaranarayanan R, Ramadas K, Thara S, Muwonge R, Prabhakar J, Augustine P, Venugopal M, Anju G, Mathew BS. Clinical breast examination: preliminary results from a cluster randomized controlled trial in India. J Natl Cancer Inst. 2011 Oct 5;103(19):1476-80
• 17.Coburn NG, Chung MA, Fulton J, Cady B. Decreased breast cancer tumor size, stage, and mortality in Rhode Island: an example of a well-screened population.Cancer Control. 2004 Jul-Aug;11(4):222-30
• 18.Kopans DB: Beyond randomized, controlled trials: organized mammographic screening substantially reduces breast cancer mortality. Cancer. 2002, 94: 580-581
• 19.Autier P, Boniol M, Gavin A, Vatten LJ: Breast cancer mortality in neighbouring European countries with different levels of screening but similar access to treatment: trend analysis of WHO mortality database. BMJ. 2011, 343: d4411
• 20.Haber G, Ahmed N.U, Pekovic V. Family History of Cancer and Its Association With Breast Cancer Risk Perception and Repeat Mammography. Am J Public Health. 2012 Dec; 102(12): 2322–2329
• 21.Tilanus-Linthorst MM, Bartels CC, Obdeijn AI, KuenenBoumeester V, Klijn JG, Oudkerk M. Good results in periodic screening in women with increased risk of breast cancer; retrospective study. Ned Tijdschr Geneeskd. 1995 Mar 4;139(9):445-9